HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3 Progressive Supranuclear Palsy

aka PSNP3

Also Known As:

Supranuclear Palsy, Progressive, 3

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
Eye Diseases: 3522
- Ocular Motility Disorders: 514
  - Ophthalmoplegia: 867
    - Progressive Supranuclear Palsy: 1232
      - 3 Progressive Supranuclear Palsy: 4
Signs and Symptoms Pathological Conditions
- Signs and Symptoms
  - Neurologic Manifestations: 7102
    - Paralysis: 14164
      - Ophthalmoplegia: 867
        Progressive Supranuclear Palsy: 1232
        3 Progressive Supranuclear Palsy: 4

Related Diseases

1.	Parkinson Disease (Parkinson's Disease)
2.	Tremor (Tremors)
3.	Striatonigral Degeneration
4.	Dementia (Dementias)
5.	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

Experts

1.	Adler, Charles H: 1 article (06/2014)
2.	Akiyama, Haruhiko: 1 article (06/2014)
3.	Arizona Parkinson's Disease Consortium: 1 article (06/2014)
4.	Beach, Thomas G: 1 article (06/2014)
5.	Carew, Jeremiah: 1 article (06/2014)
6.	Cuenca, Nicolás: 1 article (06/2014)
7.	Sabbagh, Marwan N: 1 article (06/2014)
8.	Serrano, Geidy: 1 article (06/2014)
9.	Shill, Holly A: 1 article (06/2014)
10.	Sue, Lucia I: 1 article (06/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to 3 Progressive Supranuclear Palsy:

1.	fluorodopa F 18IBA 09/01/1993 - "Postmortem counts of dopaminergic cell densities in the substantia nigra (5 subjects) and striatal levels of dopamine (DA) and its metabolites (6 subjects) were determined on 1 parkinsonian (PD), 3 progressive supranuclear palsy (PSP), 1 amyotrophic lateral sclerosis, and 1 Alzheimer's case who had been positron emission tomography scanned with 6-[18F]fluorodopa during life. " 01/01/1992 - "Positron emission tomography (PET) studies on regional cerebral glucose metabolism and [18F]fluorodopa uptake were performed on 3 patients with "pure akinesia without rigidity and tremors", 3 progressive supranuclear palsy (PSP) patients, and 5 patients with Parkinson's disease. "
2.	Glucose (Dextrose)FDA LinkGeneric 01/01/1992 - "Positron emission tomography (PET) studies on regional cerebral glucose metabolism and [18F]fluorodopa uptake were performed on 3 patients with "pure akinesia without rigidity and tremors", 3 progressive supranuclear palsy (PSP) patients, and 5 patients with Parkinson's disease. "
3.	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/01/1990 - "We investigated tyrosine-hydroxylase (TH)-immunoreactive neurons in the medulla oblongata corresponding to the A1 and A2 cell groups in autopsy tissue of patients with Parkinson's disease (PD) (n = 3), progressive supranuclear palsy (PSP) (n = 3), striatonigral degeneration (SND) (n = 2), and in controls (n = 4). "
4.	Retinaldehyde (Retinal)IBA 06/13/2014 - "Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). "
5.	Dopamine (Intropin)FDA LinkGeneric 09/01/1993 - "Postmortem counts of dopaminergic cell densities in the substantia nigra (5 subjects) and striatal levels of dopamine (DA) and its metabolites (6 subjects) were determined on 1 parkinsonian (PD), 3 progressive supranuclear palsy (PSP), 1 amyotrophic lateral sclerosis, and 1 Alzheimer's case who had been positron emission tomography scanned with 6-[18F]fluorodopa during life. "